Flow Activation Energy of High-Concentration Monoclonal Antibody Solutions and Protein–Protein Interactions Influenced by NaCl and Sucrose
The solution viscosity and protein-protein interactions (PPIs) as a function of temperature (4-40 °C) were measured at a series of protein concentrations for a monoclonal antibody (mAb) with different formulation conditions, which include NaCl and sucrose. The flow activation energy (<i>E</i><sub>η</sub>) was extracted from the temperature dependence of solution viscosity using the Arrhenius equation. PPIs were quantified via the protein diffusion interaction parameter (<i>k</i><sub>D</sub>) measured by dynamic light scattering, together with the osmotic second virial coefficient and the structure factor obtained through small-angle X-ray scattering. Both viscosity and PPIs were found to vary with the formulation conditions. Adding NaCl introduces an attractive interaction but leads to a significant reduction in the viscosity. However, adding sucrose enhances an overall repulsive effect and leads to a slight decrease in viscosity. Thus, the averaged (attractive or repulsive) PPI information is not a good indicator of viscosity at high protein concentrations for the mAb studied here. Instead, a correlation based on the temperature dependence of viscosity (i.e., <i>E</i><sub>η</sub>) and the temperature sensitivity in PPIs was observed for this specific mAb. When <i>k</i><sub>D</sub> is more sensitive to the temperature variation, it corresponds to a larger value of <i>E</i><sub>η</sub> and thus a higher viscosity in concentrated protein solutions. When <i>k</i><sub>D</sub> is less sensitive to temperature change, it corresponds to a smaller value of <i>E</i><sub>η</sub> and thus a lower viscosity at high protein concentrations. Rather than the absolute value of PPIs at a given temperature, our results show that the temperature sensitivity of PPIs may be a more useful metric for predicting issues with high viscosity of concentrated solutions. In addition, we also demonstrate that caution is required in choosing a proper protein concentration range to extract <i>k</i><sub>D</sub>. In some excipient conditions studied here, the appropriate protein concentration range needs to be less than 4 mg/mL, remarkably lower than the typical concentration range used in the literature.
Authors
- Harold W. Hatch (ORCID: https://orcid.org/0000-0003-2926-9145)
- Rahul Upadhya (ORCID: https://orcid.org/0000-0002-6268-8029)
- Steven D. Hudson (ORCID: https://orcid.org/0000-0002-3203-4833)
- Alexander Grishaev (ORCID: https://orcid.org/0000-0002-9347-2327)
- Marco A. Blanco (ORCID: https://orcid.org/0000-0001-5768-9038)
- Richard E. Gillilan (ORCID: https://orcid.org/0000-0002-7636-3188)
- Suzette A. Pabit (ORCID: https://orcid.org/0000-0002-2102-2474)
- Guangcui Yuan (ORCID: https://orcid.org/0000-0003-0063-3767)
- Sudeep Adhikari
- Jainik Panchal
- Qingqiu Huang (ORCID: https://orcid.org/0000-0002-3783-3001)
- Paul F. Salipante (ORCID: https://orcid.org/0000-0002-8692-4268)
- Yun Liu (ORCID: https://orcid.org/0000-0002-0944-3153)
- Vincent K. Shen
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- National Institute of Standards and Technology (US)
- United States Military Academy (US)
- Cornell University (US)
- Material Measurement Laboratory (US)
- NIST Center for Neutron Research (US)
- University of Delaware (US)
Publication Details
- Journal
- Molecular Pharmaceutics
- Published
- 2024-08-20
- DOI
- https://doi.org/10.1021/acs.molpharmaceut.4c00460
- Citations
- 9
- Primary Topic
- Protein purification and stability
- Type
- article
- Field-Weighted Citation Impact
- 2.10
Funders
- Empire State Development Corporation
- National Institute of General Medical Sciences
- Division of Materials Research